Table 3 Comparison of the biomarker Levels between the VTE Group and the no-VTE group, after stratification by RCOG risk scores

D-Dimer(mg/L)

7.10±5.81

7.30±5.23

0.823

5.36±5.33

6.77±6.05

0.049

Fibrinogen (g/L)

3.63±0.74

3.66±0.80

0.752

3.85±0.87

3.77±0.90

0.492

BNP(pg/ml)

66.22±64.05

77.60±78.93

0.260

80.37±82.64

99.52±100.16

0.088

Hcy (umol/L)

6.46±1.84

6.41±1.89

0.861

7.31±4.86

7.04±3.05

0.668

TG (mmol/L)

3.53±1.90

3.64±1.69

0.689

3.86±1.98

3.94±1.31

0.643

TC (mmol/L)

6.21±1.42

6.74±1.36

0.012

6.12±1.36

6.37±1.27

0.144

HDL (mmol/L)

2.08±0.46

1.95±0.43

0.067

1.97±0.47

1.86±0.45

0.105

LDL (mmol/L)

3.48±1.07

3.69±1.08

0.221

3.21±0.90

3.54±0.92

0.010

ApoA1(g/L)

1.89±0.38

1.92±0.40

0.566

1.81±0.38

1.80±0.45

0.833

ApoB(g/L)

1.28±0.32

1.34±0.26

0.182

1.29±0.29

1.32±0.32

0.468

WBC(^10⁹/L)

8.36±2.23

8.77±2.18

0.209

8.25±2.11

9.13±2.34

0.003

HCT(%)

35.75±2.81

35.69±6.37

0.950

36.13±8.38

35.30±3.42

0.372

Platelet count (10^9/L)

193.28±53.23

180.55±49.74

0.102

192.07±56.45

197.61±51.47

0.430